Meta‐analysis: Anticholinergics, but not β‐agonists, Reduce Severe Exacerbations and Respiratory Mortality in COPD

BACKGROUND: Anticholinergics and β2‐agonists have generally been considered equivalent choices for bronchodilation in chronic obstructive pulmonary disease (COPD). OBJECTIVE: To assess the safety and efficacy of anticholinergics and β2‐agonists in COPD. DESIGN: We comprehensively searched electronic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of general internal medicine : JGIM 2006-10, Vol.21 (10), p.1011-1019
Hauptverfasser:	Salpeter, Shelley R., Buckley, Nicholas S., Salpeter, Edwin E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Agonists - therapeutic use adrenergic β‐agonists Biological and medical sciences cholinergic antagonists Cholinergic Antagonists - therapeutic use chronic obstructive pulmonary disease Chronic obstructive pulmonary disease, asthma clinical outcomes COPD General aspects Humans Medical sciences meta‐analysis Miscellaneous mortality muscarinic antagonists Original Pneumology Public health. Hygiene Public health. Hygiene-occupational medicine Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - mortality Randomized Controlled Trials as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!